Siderophore-antimicrobial adjuvant conjugates as a strategy to fight antibacterial resistance

Authors

  • M. C. Almeida Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal; CIIMAR- Centro Interdisciplinar de Investigação Marinha e Ambiental, Terminal de Cruzeiros do Porto de Leixões, 4450-208 Matosinhos, Portugal.
  • P. M. da Costa CIIMAR- Centro Interdisciplinar de Investigação Marinha e Ambiental, Terminal de Cruzeiros do Porto de Leixões, 4450-208 Matosinhos, Portugal; ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
  • E. Sousa Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal; CIIMAR- Centro Interdisciplinar de Investigação Marinha e Ambiental, Terminal de Cruzeiros do Porto de Leixões, 4450-208 Matosinhos, Portugal.
  • D. I. S. P. Resende Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal; CIIMAR- Centro Interdisciplinar de Investigação Marinha e Ambiental, Terminal de Cruzeiros do Porto de Leixões, 4450-208 Matosinhos, Portugal.

DOI:

https://doi.org/10.48797/sl.2023.76

Keywords:

Poster

Abstract

Background: The levels of drug resistance to traditional antibiotics have been dramatically increasing constituting a threat to global health.[1] For this reason, the pursuit of alternative strategies to the discovery of novel antibacterial agents is a priority.[2] Emerging approaches include the development of target-directed compounds through the conjugation of antibiotics with moieties that will improve antibacterial activity.[2] A promising example is the conjugation of antibiotics with siderophores/siderophore mimetics able to highjack iron transport systems of bacteria acting as “Trojan Horses” [3, 4]. Objective: In this work, we aimed to synthesize conjugated molecules between siderophores/siderophore mimetics and antimicrobial adjuvants to obtain dual action compounds. Future goals also include the evaluation of the antibacterial activity and synergism potential of the compounds as well as the assessment of their effect on common resistant models. Methods/Results: Siderophore mimetics were synthesized through a variety of synthetic pathways. Then, two sequential coupling reactions were performed to connect the antibacterial adjuvant, the linker moiety and the siderophore or the siderophore mimetic. Structural elucidation of the compounds was obtained by nuclear magnetic resonance techniques (NMR). Conclusions: Siderophore-antimicrobial adjuvant conjugates described in this work were successfully synthetized and are expected to reveal potential as a novel approach to fight antimicrobial resistance.

References

1. Nathan, C. Resisting antimicrobial resistance. Nat. Rev. Microbiol., 2020, 18, 259-260.

2. Almeida, M. C.; da Costa, P. M.; Sousa, E.; Resende, D. I. S. P. Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections. J. Med. Chem. 2023, 66, 32-70.

3. Negash, K. H.; Norris, J. K. S.; Hodgkinson, J. T. Siderophore–antibiotic conjugate design: new drugs for bad bugs? Molecules 2019, 24, 3314.

4. Choi, J. J.; McCarthy, M. W. Cefiderocol: a novel siderophore cephalosporin. Expert Opin Investig Drugs 2018, 27, 193-197.

Downloads

Published

2023-04-21

How to Cite

Almeida , M. C., da Costa , P. M., Sousa , E., & Resende , D. I. S. P. (2023). Siderophore-antimicrobial adjuvant conjugates as a strategy to fight antibacterial resistance. Scientific Letters, 1(Sup 1). https://doi.org/10.48797/sl.2023.76

Issue

Section

Posters

Most read articles by the same author(s)

Similar Articles

<< < 11 12 13 14 15 16 

You may also start an advanced similarity search for this article.